Cargando…
Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department
We describe and analyze a “care as usual” strategy of a French Comprehensive Cancer Center during the COVID-19 pandemic to manage surgical patients with gynecological cancer. We conducted a retrospective analysis evaluating the surgical activity in our gynecologic oncology department between January...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097084/ https://www.ncbi.nlm.nih.gov/pubmed/33968755 http://dx.doi.org/10.3389/fonc.2021.653009 |
_version_ | 1783688281459785728 |
---|---|
author | Blache, Guillaume El Hajj, Houssein Jauffret, Camille Houvenaeghel, Gilles Sabiani, Laura Barrou, Julien Masquin, Isabelle Le Saout, Jérémy Mokart, Djamel Faucher, Marion Lambaudie, Eric |
author_facet | Blache, Guillaume El Hajj, Houssein Jauffret, Camille Houvenaeghel, Gilles Sabiani, Laura Barrou, Julien Masquin, Isabelle Le Saout, Jérémy Mokart, Djamel Faucher, Marion Lambaudie, Eric |
author_sort | Blache, Guillaume |
collection | PubMed |
description | We describe and analyze a “care as usual” strategy of a French Comprehensive Cancer Center during the COVID-19 pandemic to manage surgical patients with gynecological cancer. We conducted a retrospective analysis evaluating the surgical activity in our gynecologic oncology department between January 21 and May 12, 2020. We compared the surgical activity and surgical and oncologic outcomes during the pre-lockdown period and the pandemic period. The main objective was to evaluate the impact of the COVID-19 pandemic on surgical activity. The secondary objectives were to analyze the surgical and the oncologic outcomes. We compared the surgical activity during the 8 weeks after the national lockdown (85 procedures) to the surgical activity in the 8 weeks preceding the lockdown (127 procedures). We observed a 33% decrease in activity between the two periods. The clinical and epidemiologic characteristics were similar between the two periods. There were no differences between the surgical approaches (p = 0.592), the surgical complexity (p = 0.323), the length of stay (p = 0.85), and even for the complex procedure (p = 0.96) and the perioperative (p = 0.791) and postoperative complication rates (p = 0.102). We observed a significant decrease in the time of return to intended oncological treatment (RIOT) during the lockdown period with an average of 31.9 days compared to 46.9 days in the pre-lockdown period (p = 0.003). During the COVID-19 pandemic, “care as usual” represents an acceptable strategy without impairing the oncologic outcome in a Comprehensive Cancer Center with a patient-centered clinical pathway for gynecologic oncologic surgical patients. |
format | Online Article Text |
id | pubmed-8097084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80970842021-05-06 Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department Blache, Guillaume El Hajj, Houssein Jauffret, Camille Houvenaeghel, Gilles Sabiani, Laura Barrou, Julien Masquin, Isabelle Le Saout, Jérémy Mokart, Djamel Faucher, Marion Lambaudie, Eric Front Oncol Oncology We describe and analyze a “care as usual” strategy of a French Comprehensive Cancer Center during the COVID-19 pandemic to manage surgical patients with gynecological cancer. We conducted a retrospective analysis evaluating the surgical activity in our gynecologic oncology department between January 21 and May 12, 2020. We compared the surgical activity and surgical and oncologic outcomes during the pre-lockdown period and the pandemic period. The main objective was to evaluate the impact of the COVID-19 pandemic on surgical activity. The secondary objectives were to analyze the surgical and the oncologic outcomes. We compared the surgical activity during the 8 weeks after the national lockdown (85 procedures) to the surgical activity in the 8 weeks preceding the lockdown (127 procedures). We observed a 33% decrease in activity between the two periods. The clinical and epidemiologic characteristics were similar between the two periods. There were no differences between the surgical approaches (p = 0.592), the surgical complexity (p = 0.323), the length of stay (p = 0.85), and even for the complex procedure (p = 0.96) and the perioperative (p = 0.791) and postoperative complication rates (p = 0.102). We observed a significant decrease in the time of return to intended oncological treatment (RIOT) during the lockdown period with an average of 31.9 days compared to 46.9 days in the pre-lockdown period (p = 0.003). During the COVID-19 pandemic, “care as usual” represents an acceptable strategy without impairing the oncologic outcome in a Comprehensive Cancer Center with a patient-centered clinical pathway for gynecologic oncologic surgical patients. Frontiers Media S.A. 2021-04-21 /pmc/articles/PMC8097084/ /pubmed/33968755 http://dx.doi.org/10.3389/fonc.2021.653009 Text en Copyright © 2021 Blache, El Hajj, Jauffret, Houvenaeghel, Sabiani, Barrou, Masquin, Le Saout, Mokart, Faucher and Lambaudie. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Blache, Guillaume El Hajj, Houssein Jauffret, Camille Houvenaeghel, Gilles Sabiani, Laura Barrou, Julien Masquin, Isabelle Le Saout, Jérémy Mokart, Djamel Faucher, Marion Lambaudie, Eric Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department |
title | Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department |
title_full | Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department |
title_fullStr | Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department |
title_full_unstemmed | Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department |
title_short | Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department |
title_sort | care as usual: an acceptable strategy to apply during the covid-19 pandemic in a french tertiary gynecologic oncology department |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097084/ https://www.ncbi.nlm.nih.gov/pubmed/33968755 http://dx.doi.org/10.3389/fonc.2021.653009 |
work_keys_str_mv | AT blacheguillaume careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment AT elhajjhoussein careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment AT jauffretcamille careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment AT houvenaeghelgilles careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment AT sabianilaura careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment AT barroujulien careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment AT masquinisabelle careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment AT lesaoutjeremy careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment AT mokartdjamel careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment AT fauchermarion careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment AT lambaudieeric careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment |